Tarsus Pharmaceuticals Stock (NASDAQ:TARS), Quotes and News Summary

Q: What sector and industry does Tarsus Pharmaceuticals (TARS) operate in?

Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Tarsus Pharmaceuticals Stock (NASDAQ: TARS) stock price, news, charts, stock research, profile.

Open	$32.440
Close	$32.440
Volume / Avg.	657.454K / 757.885K
Day Range	31.720 - 33.690
52 Wk Range	12.480 - 40.400
Market Cap	$1.217B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	21.93%
Days to Cover	16.12

Recent News

ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Avi Kapoor

SoFi Technologies Posts Q4 Earnings, Joins Cardlytics, McGrath RentCorp And Other Big Stocks Moving Higher On Monday

U.S. stocks traded mixed, with the Dow Jones trading slightly lower on Monday. Shares of SoFi Technologies, Inc. (NASDAQ: SOFI) rose sharply during Monday’s session after the company reported better-than-expected fourth-quarter revenue.

Avi Kapoor

Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Wynn Resorts, Limited (NASDAQ: WYNN) fell sharply on Friday after the company reported third-quarter financial results.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Tarsus Pharmaceuticals Inc

Sector

Health Care

Industry

Pharmaceuticals

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the developmen...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tarsus Pharmaceuticals (TARS) stock?

You can purchase shares of Tarsus Pharmaceuticals (NASDAQ: TARS) through any online brokerage.

View our list of the best stock brokerages.

Who are Tarsus Pharmaceuticals's (TARS) competitors?

Other companies in Tarsus Pharmaceuticals’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Neumora Therapeutics (NASDAQ:NMRA), ANI Pharmaceuticals (NASDAQ:ANIP) and Longboard Pharmaceuticals (NASDAQ:LBPH).

What is the target price for Tarsus Pharmaceuticals (TARS) stock?

The latest price target for Tarsus Pharmaceuticals (NASDAQ: TARS) was reported by Jefferies on Wednesday, March 6, 2024. The analyst firm set a price target for 44.00 expecting TARS to rise to within 12 months (a possible 35.64% upside). 16 analyst firms have reported ratings in the last year.

Current Stock Price for Tarsus Pharmaceuticals (TARS)?

The stock price for Tarsus Pharmaceuticals (NASDAQ: TARS) is $32.44 last updated April 19, 2024 at 4:00 PM EDT.

Does Tarsus Pharmaceuticals (TARS) pay a dividend?

There are no upcoming dividends for Tarsus Pharmaceuticals.

When is Tarsus Pharmaceuticals (NASDAQ:TARS) reporting earnings?

Tarsus Pharmaceuticals’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Is Tarsus Pharmaceuticals (TARS) going to split?

There is no upcoming split for Tarsus Pharmaceuticals.

What sector and industry does Tarsus Pharmaceuticals (TARS) operate in?

Tarsus Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-